November 22, 2016 - Announcements

ViewnVivo - Redefining Preclinical Research Insight

Optiscan is delighted to announce the official launch of its 2nd generation Preclinical Research product; ViewnVivo.
ViewnVivo is a miniaturised fluorescence endomicroscope platform that brings the next generation of Optiscan's incredible imaging capability and flexibility to Preclinical Research.

Users of ViewnVivo can capture high resolution, real-time in vivo images with submicron detail and view them in stunning quality for faster Preclinical Research insights.

ViewnVivo represents a significant improvement to the existing competitor's product offering in the research market providing major benefits including:

  • Stunning image quality
  • Interactive and continuously variable imaging depth control
  • Greater sensitivity for even better image capture
  • Validated capability
  • Miniaturised without sacrificing image resolution
  • Real-time In Vivo insight
  • Flexibility of operation
  • No dedicated technician or facility required
  • Self-calibration and simplicity ensures immediate usability
  • Patented technology
  • Acceleration of research capability

For more information please go to the dedicated website: viewnvivo.com

Optiscan Imaging Limited published this content on 22 November 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 November 2016 05:43:06 UTC.

Original documenthttp://www.optiscan.com/2016/11/22/preclinical-research-product-launch/

Public permalinkhttp://www.publicnow.com/view/430C210769A8E63B9D4EF5CB492989B10430BF1D